In addition, APP-SL 7-5 Tg mice were administered nobiletin daily from 4 to 9 months of age, and it significantly reversed memory impairment without affecting general behavior in the context-dependent fear conditioning test and reduced quantity of Aβ1-42 and Aβ1-40 in the brain [24]. Here, APP is linked to memory impairment.